ShopSpell

Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimers Disease: Vol [Hardcover]

$252.99       (Free Shipping)
133 available
  • Category: Books (Medical)
  • ISBN-10:  1774919443
  • ISBN-10:  1774919443
  • ISBN-13:  9781774919446
  • ISBN-13:  9781774919446
  • Publisher:  Apple Academic Press
  • Publisher:  Apple Academic Press
  • Pages:  322
  • Pages:  322
  • Binding:  Hardcover
  • Binding:  Hardcover
  • SKU:  1774919443-11-MPOD
  • SKU:  1774919443-11-MPOD
  • Item ID: 107199342
  • Seller: ShopSpell
  • Ships in: 2 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 05 to Oct 07
  • Notes: Brand New Item. Not shipped to AK, HI, APO, FPO, AE.

PART I: NUTRACEUTICALS: HOLISTIC APPROACHES TO ALZHEIMERS MANAGEMENT 1. Emergent Natural Antioxidant Therapeutics to Cope with Oxidative Stress in Alzheimers Disease 2. Exploring Beta Secretase Inhibitors as the Evergreen Drug Target for Alzheimers Disease: Calling Herbal Therapies to the Rescue 3. Role of Natural Steroidal Phytopharmaceuticals in the Management of Alzheimers Disease 4. Potential Role of Terpenes in the Management of Alzheimers Disease 5. Anti-Apoptotic Natural Products for the Management of Alzheimers Disease 6. Potential Natural Polysaccharides for the Management of Alzheimers Disease 7. Neuro-Protective Role of Vitamin D in Alzheimers Disease 8. Role of Non-Flavonoidal Agents in Alzheimers Disease PART II: RECENT DEVELOPMENTS AND ADVANCEMENTS IN THE DELIVERY OF NUTRACEUTICALS ACROSS BLOOD-BRAIN-BARRIER 9. Drug Delivery Strategies for Drug Targeting for Alzheimers Disease 10. Nanocargos for Efficient Delivery of Nutraceuticals Across Blood-Brain Barrier 11. Recent Advancement in Strategies for Delivery of Neuronutraceuticals to the Brain

Details latest strategies for the pursuit of effective Alzheimers management. Explores nutraceuticals and their pivotal role in managing Alzheimers disease. Discusses various potential therapies for the effective treatment of Alzheimers. Recent developments and advancements in the delivery of nutraceuticals are also explored.

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of natures pharmacopeia in our battle against Alzheimers disease.

Volume 2: StratelÓ4